Application Nr Approved Date Route Status External Links
NDA208223 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Zembrace Symtouch Is Indicated For The Acute Treatment Of Migraine With Or Without Aura In Adults. Limitations Of Use: Use Only If A Clear Diagnosis Of Migraine Has Been Established. If A Patient Has No Response To The First Migraine Attack Treated With Zembrace Symtouch, Reconsider The Diagnosis Before Zembrace Symtouch Is Administered To Treat Any Subsequent Attacks. Zembrace Symtouch Injection Is Not Indicated For The Prevention Of Migraine Attacks. Zembrace Symtouch Is A Serotonin (5-Ht 1b/1d ) Receptor Agonist (Triptan) Indicated For: Acute Treatment Of Migraine With Or Without Aura In Adults ( 1 ) Limitations Of Use: Use Only If A Clear Diagnosis Of Migraine Has Been Established. ( 1 ) Not Indicated For The Prophylactic Therapy Of Migraine. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Sumatriptan Succinate SUMATRIPTAN SUCCINATE ZINC14360

Comments